5-MeO-DMT induces sleep-like LFP spectral signatures in the hippocampus and prefrontal cortex of awake rats.
Annie C SouzaBryan C SouzaArthur Cavalcanti de FrançaMarzieh MoradiNicholy C SouzaKatarina E LeãoAdriano B L TortRichardson N LeãoVítor Lopes-Dos-SantosSidarta RibeiroPublished in: Scientific reports (2024)
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a potent classical psychedelic known to induce changes in locomotion, behaviour, and sleep in rodents. However, there is limited knowledge regarding its acute neurophysiological effects. Local field potentials (LFPs) are commonly used as a proxy for neural activity, but previous studies investigating psychedelics have been hindered by confounding effects of behavioural changes and anaesthesia, which alter these signals. To address this gap, we investigated acute LFP changes in the hippocampus (HP) and medial prefrontal cortex (mPFC) of freely behaving rats, following 5-MeO-DMT administration. 5-MeO-DMT led to an increase of delta power and a decrease of theta power in the HP LFPs, which could not be accounted for by changes in locomotion. Furthermore, we observed a dose-dependent reduction in slow (20-50 Hz) and mid (50-100 Hz) gamma power, as well as in theta phase modulation, even after controlling for the effects of speed and theta power. State map analysis of the spectral profile of waking behaviour induced by 5-MeO-DMT revealed similarities to electrophysiological states observed during slow-wave sleep (SWS) and rapid-eye-movement (REM) sleep. Our findings suggest that the psychoactive effects of classical psychedelics are associated with the integration of waking behaviours with sleep-like spectral patterns in LFPs.
Keyphrases
- prefrontal cortex
- sleep quality
- physical activity
- optical coherence tomography
- liver failure
- healthcare
- working memory
- drug induced
- transcranial magnetic stimulation
- computed tomography
- depressive symptoms
- gene expression
- magnetic resonance
- aortic dissection
- dual energy
- deep brain stimulation
- cognitive impairment
- acute respiratory distress syndrome
- single molecule
- high density